Evidence map›Paper›PMID 38869447›Full record

ArticleDiabetes2024

Diabetic Wound Keratinocytes Induce Macrophage JMJD3-Mediated Nlrp3 Expression via IL-1R Signaling.

Sonya J Wolf, Christopher O Audu, Jadie Y Moon, Amrita D Joshi, William J Melvin, Emily C Barrett, Kevin Mangum, Gabriela Saldana de Jimenez, Sabrina Rocco, Sam Buckley and 6 more

Abstract read
In one paragraph

Article in Diabetes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Fibroblasts resistScience advances · 2026
    Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Sonya J WolfSection of Vascular Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI.ORCID 0000-0003-3626-9274
Christopher O AuduSection of Vascular Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI.
Jadie Y MoonSection of Vascular Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI.
Amrita D JoshiSection of Vascular Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI.
William J MelvinSection of Vascular Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI.
Emily C BarrettSection of Vascular Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI.
Kevin MangumSection of Vascular Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI.
Gabriela Saldana de JimenezSection of Vascular Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI.
Sabrina RoccoSection of Vascular Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI.
Sam BuckleySection of Vascular Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI.
Zara AhmedSection of Vascular Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI.
Rachael WasikowskiDepartment of Dermatology, University of Michigan, Ann Arbor, MI.
J Michelle KahlenbergDepartment of Dermatology, University of Michigan, Ann Arbor, MI.
Lam C TsoiDepartment of Dermatology, University of Michigan, Ann Arbor, MI.
Johann E GudjonssonDepartment of Dermatology, University of Michigan, Ann Arbor, MI.
Katherine A GallagherSection of Vascular Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI.ORCID 0000-0002-8791-6980

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DAVID P OLSON · 2013 to 2026
$24.3M
Pilot and Feasibility (P and F) ProgramP30DK089503 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Karen Eileen Peterson · 2010 to 2026
$20.3M
Michigan IRACDA: Training Future Professors of Engineering and PhysiologyK12GM111725 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BROOKS, SUSAN V, SEPT, DAVID · 2016 to 2025
$7.9M
University of Michigan Skin Biology and Diseases Resource-based CenterP30AR075043 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Johann Eli Gudjonsson · 2019 to 2026
$6.6M
The epigenetic regulation of inflammation in tissue repair and vascular diseaseR35HL167143 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Katherine Ann Gallagher · 2023 to 2026
$4.2M
Targeting jmjd3 mitigates heterotopic ossificationR01AR079863 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Katherine Ann Gallagher, Benjamin Levi · 2021 to 2026
$3.0M
Notch signaling in diabetic woundsR01DK127531 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GALLAGHER, KATHERINE ANN · 2021 to 2024
$2.5M
Nanomedicine-Based Targeting of Inflammatory Macrophages in Diabetic Wound RepairR01DK131782 · NIDDK · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI Katherine Ann Gallagher, Andrew Michael Smith · 2022 to 2026
$2.4M
The Interferon-beta (IFN-beta)/SETDB2 Epigenetic Axis Regulates Inflammation And Metabolism In Diabetic WoundsR01HL137919 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GALLAGHER, KATHERINE ANN · 2017 to 2021
$2.4M
Epigenetic Regulation of Prostaglandin E2 (PGE2) Synthesis Alters Macrophage Function to Promote Inflammation and Impair Diabetic Wound HealingR01DK124290 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GALLAGHER, KATHERINE ANN, MOORE, BETHANY B. · 2020 to 2023
$1.8M
JMJD3 Regulates Abdominal Aortic Aneurysm ExpansionR01HL156274 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GALLAGHER, KATHERINE ANN · 2021 to 2022
$1.1M
Role of IFN kappa in psoriasis-mediated diabetes developmentR00DK133828 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Sonya J Wolf-Fortune · 2024 to 2026
$747k
Michigan Nutrition Obesity Research Center, Medical School, University of Michigan P30-DK089503NHLBI NIH HHS R01 HL137919NHLBI NIH HHS R01 HL156274NHLBI NIH HHS R35 HL167143NIAMS NIH HHS P30 AR075043NIAMS NIH HHS R01 AR079863NIDDK NIH HHS K99 DK133828NIDDK NIH HHS P30 DK020572NIDDK NIH HHS P30 DK089503NIDDK NIH HHS R00 DK133828NIDDK NIH HHS R01 DK124290NIDDK NIH HHS R01 DK127531NIDDK NIH HHS R01 DK131782NIGMS NIH HHS K12 GM111725NIH HHS K12-GM111725
6 · The paper itself

Abstract

Macrophage (Mφ) plasticity is critical for normal wound repair; however, in type 2 diabetic wounds, Mφs persist in a low-grade inflammatory state that prevents the resolution of wound inflammation. Increased NLRP3 inflammasome activity has been shown in diabetic wound Mφs; however, the molecular mechanisms regulating NLRP3 expression and activity are unclear. Here, we identified that diabetic wound keratinocytes induce Nlrp3 gene expression in wound Mφs through IL-1 receptor-mediated signaling, resulting in enhanced inflammasome activation in the presence of pathogen-associated molecular patterns and damage-associated molecular patterns. We found that IL-1α is increased in human and murine wound diabetic keratinocytes compared with nondiabetic controls and directly induces Mφ Nlrp3 expression through IL-1 receptor signaling. Mechanistically, we report that the histone demethylase, JMJD3, is increased in wound Mφs late post-injury and is induced by IL-1α from diabetic wound keratinocytes, resulting in Nlrp3 transcriptional activation through an H3K27me3-mediated mechanism. Using genetically engineered mice deficient in JMJD3 in myeloid cells (Jmjd3f/flyz2Cre+), we demonstrate that JMJD3 controls Mφ-mediated Nlrp3 expression during diabetic wound healing. Thus, our data suggest a role for keratinocyte-mediated IL-1α/IL-1R signaling in driving enhanced NLRP3 inflammasome activity in wound Mφs. These data also highlight the importance of cell cross-talk in wound tissues and identify JMJD3 and the IL-1R signaling cascade as important upstream therapeutic targets for Mφ NLRP3 inflammasome hyperactivity in nonhealing diabetic wounds. ARTICLE HIGHLIGHTS:

Indexed as

InflammasomesJumonji Domain-Containing Histone DemethylasesKeratinocytesMacrophagesNLR Family, Pyrin Domain-Containing 3 ProteinReceptors, Interleukin-1Signal TransductionWound HealingAnimalsDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2HumansInterleukin-1alphaMaleMiceMice, Inbred C57BLInflammasomesInterleukin-1alphaJumonji Domain-Containing Histone DemethylasesKDM6B protein, humanKdm6b protein, mouseNLR Family, Pyrin Domain-Containing 3 ProteinNLRP3 protein, humanNlrp3 protein, mouseReceptors, Interleukin-1

Identifiers

PMID38869447
PMCPMC11333374

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.